Cipla scales up imports as Moderna gets Indian vaccine nod June 30, 2021 The Indian government has approved imports of Moderna’s SARS-COV-2 vaccine, to be handled by Cipla, as it seeks to tackle the pandemic via both imports and retention of domestically produced vaccines. Cipla’s supply chain activity has already been increasing with Indian imports linked to the f... Read more →
4Q 2019 Outlook: A Range of Convenient Enemies – U.S. Trade Policy October 1, 2019 U.S. trade policy is likely to become more rather than less complicated during the fourth quarter, with seven major issues to watch. The passage of the U.S.-Mexico-Canada Agreement may be accelerated as a result of the impeachment process, but in the meantime the U.S. trade deficit with Mexico... Read more →
Dr Reddy’s Ready for Growth As Imports Surge After Quiet Quarter October 30, 2018 Generic drug manufacturer Dr. Reddy’s Labs reported third quarter revenues in the U.S. that fell by 0.3% on a year earlier. The company cites declining prices as a major factor, which can also be seen in the 13.6% drop in average import values per gram for U.S. imports of all pharmaceuticals. ... Read more →
India
中文